{"entity":{"type":"insider","cik":"0001617554","url":"/insider/0001617554","json_url":"/insider/0001617554.json","name":"Elizabeth Charuvastra Exemption Trust","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2014-08-21","last":"2014-08-21","span_basis":"filed_date"},"name_variants":[{"name":"Elizabeth Charuvastra Exemption Trust","source":"filing","n_filings":2,"first_seen":"2014-08-21","last_seen":"2014-08-21"}],"transactions":[{"id":6195139,"accession":"0001493152-14-002681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-14-002681","line_url":"/filing/0001493152-14-002681#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001617554","owner_name":"Elizabeth Charuvastra Exemption Trust","owner_url":"/insider/0001617554","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101035.0,"shares_display":"101,035","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":40414.0,"total_display":"40,414.00","shares_owned_after":295473.0,"shares_owned_after_display":"295,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-21","scope":"insider"},{"id":6659240,"accession":"0001493152-14-002677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-14-002677","line_url":"/filing/0001493152-14-002677#line-1","is_derivative":false,"issuer_cik":"0001420030","issuer_name":"Targeted Medical Pharma, Inc.","issuer_ticker":"TRGM","issuer_name_source":null,"issuer_url":"/issuer/0001420030","owner_cik":"0001617554","owner_name":"Elizabeth Charuvastra Exemption Trust","owner_url":"/insider/0001617554","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398965.0,"shares_display":"398,965","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":159586.0,"total_display":"159,586.00","shares_owned_after":265799.0,"shares_owned_after_display":"265,799","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-24","filed_date":"2014-08-21","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001420030","name":"Targeted Medical Pharma, Inc.","url":"/issuer/0001420030","role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","n_filings":2,"first_seen":"2014-08-21","last_seen":"2014-08-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001617554","retrieved_at":"2026-08-21T16:13:32+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}